Sonia Corrent

Discussion concerning federal vaping product excise tax in annual budget implementation acts as it relates to enforcement, rate, and impact on stakeholders. Canada Gazette, Part I, Volume 155, Number 25: Order Amending Schedules 2 and 3 to the Tobacco and Vaping Products Act (Flavours) Lobby efforts focus on flavour ban impact to small business, illicit market, and consumer behavior post ban based on lived experience.

Policy measures to ensure security of drug supply in Canada and preserve Canada's attractiveness for biopharmaceutical launches, including in response to foreign pricing regulations Food and Drug regulations as it relates to data protection and the regulation and protection of biopharmaceutical products Canada's Drug Agency (CDA) policies as it relates to health economics assessment and recommendations made on new medicines. Policy measures to ensure security of drug supply in Canada and preserve Canada's attractiveness for biopharmaceutical launches, including in response to foreign pricing regulations. Free Trade agreements as they relate to the biopharmaceutical industry Policy and Programs Health Canada and Public Health Agency of Canada policies and programs to prevent and treat HIV and eliminate hepatitis as a public health threat by 2030, as part of Canada's commitments under the Global Viral Hepatitis Strategy and therapeutic efforts against the fight for COVID-19. Patent Act Regulations as they relate to the regulation of intellectual property for therapeutic products, specifically the Patented Medicines (Notice of Compliance) Regulations Patented Medicine Prices Review Board (PMPRB) Regulations with regard to reporting requirements, pricing, guidelines and dispute resolution. Innovation Agenda, particularly with respect to initiatives to support and attract investments in the life sciences sector Federal Government First Nations and Inuit Health Branch program with respect to health services. Federally-funded Public Drug Plans, with respect to reimbursement for drug products for federal plan beneficiaries.

ADVOCATE FOR IMPROVED AWARENESS, PREVENTION AND MANAGEMENT OF WOMEN'S HEART AND BRAIN HEALTH RISK FACTORS THROUGH BILL S-243, AN ACT TO ESTABLISH A NATIONAL FRAMEWORK FOR WOMEN'S HEALTH IN CANADA ADVOCATE FOR A MODERNIZED CHARITABLE TAXATION FRAMEWORK THAT STRENGTHENS CHARITIES AND THEIR ABILITY TO MOBILIZE RESOURCES FOR THE BENEFIT OF CANADIANS. FINALIZE REGULATIONS TO RESTRICT VAPE FLAVOURS (INCLUDING MINT/MENTHOL); INTRODUCE PLAIN AND STANDARDIZED PACKAGING FOR VAPING PRODUCTS; INCREASE TOBACCO AND VAPE TAXES; IMPLEMENT A TOBACCO COST RECOVERY FEE; PROTECT EXISTING NICOTINE POUCH REGULATIONS; BAN INTERNET/ONLINE SALES FOR TOBACCO AND E-CIGARETTES; PROHIBIT THE SALE OF TOBACCO PRODUCTS AMONGST INDIVIDUALS BORN BEFORE A DETERMINED YEAR; INCREASE THE MINIMUM LEGAL AGE OF SALE FOR TOBACCO AND VAPING PRODUCTS TO 21 YEARS OF AGE. SUPPORT POLICIES THAT ELIMINATE FINANCIAL BARRIERS TO SPORT PARTICIPATION FOR CHILDREN AND YOUTH, WHILE ENSURING SPORT PARTICIPATION FUNDING IS ROLLED OUT IN AN ACCESSIBLE, EQUITABLE, AND INCLUSIVE MANNER. ADVOCATE FOR GOVERNMENT ACTION TO REDUCE THE CONSUMPTION OF, AND HARMS ASSOCIATED WITH, ULTRA-PROCESSED FOODS. ADVOCATE FOR AND FUND EQUITABLE ACCESS TO PALLIATIVE CARE PROGRAMS FOR CANADIANS, INCLUDING EQUITY-SEEKING GROUPS. INTRODUCTION OF A NATIONAL PHARMACARE PROGRAM IMPLEMENT REGULATIONS TO RESTRICT COMMERCIAL MARKETING OF UNHEALTHY FOODS AND BEVERAGES TO CHILDREN IMPLEMENT A TAX ON SUGARY DRINKS. REVENUES FROM SUCH A TAXATION STREAM SHOULD BE USED TO SUBSIDIZE HEALTHY EATING INITIATIVES FUND PUBLIC AWARENESS FOR IMPROVED USE OF DEFIBRILLATORS AND CPR. ADVOCATE FOR A TAX-EXEMPTION ON THE SALE OF DEFIBRILLATORS. ENSURE THAT THE DEDICATED FEDERAL ACTIVE TRANSPORTATION INFRASTRUCTURE FUND BECOMES A PERMANENT ENVELOPE IN CANADA'S INFRASTRUCTURE FUNDING.

Any new legislative or regulatory proposals or policies relating to tobacco and/or vaping including taxation, product regulation, flavouring, packaging and labeling requirements, contraband and general border security policy. Tobacco and Vaping Products Act with regards to the classification of tobacco and vaping products, product regulation, packaging and labeling. Schedule 1 of the Excise Act 2001 (Sections 42, 43.1 and 58.2, subsections 216(2) and (3), and section 240) under the Rate of Duty on Tobacco Products Excise Act, 2001 -with regard to tobacco and vaping duties, stamps or collection. Customs Act/Customs Tariff - with regard to customs duties on tobacco and vaping products. Any new legislative or regulatory proposals, or policies, as it pertains to combustible tobacco products and/or vaping products. Any new legislative or regulatory proposals or policies relating to the recycling of tobacco-related and vaping products.

Tobacco and Vaping Products Act with regards to the classification of tobacco and vaping products, product regulation, packaging and labeling Schedule 1 of the Excise Act 2001 (Sections 42, 43.1 and 58.2, subsections 216(2) and (3), and section 240) under the Rate of Duty on Tobacco Products Excise Act, 2001 -with regard to tobacco and vaping duties, stamps or collection. Customs Act/Customs Tariff - with regard to customs duties on tobacco and vaping products. Any new legislative or regulatory proposals or policies relating to tobacco and/or vaping including taxation, product regulation, flavouring, packaging and labeling requirements and contraband. Any new legislative or regulatory proposals or policies relating to the recycling of tobacco-related and vaping products. Any new legislative or regulatory proposals, or policies, relating to non-combustible, smoke-free, nicotine products Any new legislative or regulatory proposals, or policies, relating to harm reduction as it pertains to combustible tobacco products.